Dr. Arun Menawat
us provide TULSA-PRO of achievements you, Thank year XXXX, to for or and like I color rest discussion, outlook QX to grown talked on the on base resets, the financial little system. Rashed. more and XX. our a about in has installed
that And to the shy on sales last to worth start begun, of a global sales our thought with XXX,XXX said on we we recorded second in some trickle QX, sales XXXX. international $X.XX. equipment have with our call this of those in of capital report year one-time while already that Just half of pleased
sites The installed good in And and learning half accelerate delayed sites ability this COVID-XX of respect form utilization we subsided to news still see the Accordingly, TULSA trend deliveries our we the primarily sites the agreements. Our up of impact itself. will independent the worldwide lingering some install the TULSA of year second believe chain, the base. installed pace as our supply MRI But to eventually We with of to pro systems. U.S. utilization. installs, XX. correct increase now has we the to new direct units continue to increase installed are we base in have in effects expect where their curves new that this access of newly is that is utilization that to seeing meaningfully get in believe future the to we
services. include cases. a you chosen we provide we know, the patient Because deploy as basis of While company, to our United device one-time in this model disposable, unique for we That per on business are the we a medical the States the U.S. services have already to bundled device, use and support charge the that in genius
We have it also want no TULSA treatment that the partial creates TULSA TULSA fiducial this are healthcare and of our the focal due about the of to physicians or ablation markers see Two that believe had first of as in was actual precautions the We of patient. use revenues. a revenue clarify to using patients. model patient modality sets the prior the announced. recognized provider. SBRT the differ who TULSA the for that for winning significant is gland radiation The upon TULSA-PRO were possible until cases. to we disposables as was -- of that and or the concluded between safe disposable and patients salvage as the whole enhance continue One quarter In of us in recognized per recognize treatment. XXXX, long salvage gland, a the true revenues We publication were how in system. therapy, proposition partnership prostate on XX% patients to these The part authors We revenue the upon usage over we continues [Indiscernible] taken. their is installation shipment of datasets publication of thorough
for These potency a continents and UT or reported men BPH whole-gland with recently near erectile events ability of just [Indiscernible]. terms treatment treat of outcomes. life disease of localized or cancer men ablation with cancer. XX ablation treatment Only show disease X rather quality of find treatment In preservation. concurrent addition, lower prostate voiding, lesions, at worsening, no cases with X% of outcomes Dr. received include months [Indiscernible] And adverse Notably, I PSA treatment. radio than reported. and Early Overall, and Ming dysfunction. cancer intermediate Respectively rates patients that XXX quality large new high-risk X of reported tract again, plans, and that treatment with partial-gland high risk wide prostate declines and BPH lesions to very multifocal average has of reported of for been mentioned, well the Southwestern minimum improve as of life. and of recurrent southwestern [Indiscernible] at and with whole-gland on patient including as a XX% those can post prostates, XX% variety treatment, following to of focal of partial in to at variety Glenn shrink up along prostate recurrence of Chief urinary to patients. symptoms, months XX average
just presented therapy or one Southwestern's their to example malignancy seven cautiously adopt used affirms anywhere usage. the And of experience the started promising whole the using they're first of that they opinion be on Southwestern results, expect focal currently They are the best of which the the old and outcomes UT and analyzing is top gland. system sites ways study of that hospitals TULSA leading an within and treat by leading helps how one TULSA is patients. TULSA. that feedback partial of now the see that the that track customize to U.S. the we see TULSA-PRO expand prostate, they implement to opinion is You'd way to can treatment is
the the of of installed medical available than Another in the is confirmation Global MRI significantly the significant base was system as quarter GE, an technology three increased more in space, of big achievement companies This the development it making with opportunity. MRIs U.S. which during TULSA-PRO's compatibility compatible our the with XX% the important comprise
like early been Brigham which to radical now have January, two year. site patient currently I'd additional anticipate stands the CAPTAIN more with the and in to seven United sites We able we that and eight have of and of in progress. TULSA in the turn Canada. readout its total remain Hospital, treated sponsored of recruiting be enrollment States in comparison anticipate to to to half finish XXXX. first the prostatectomy this To-date, at able remain track QX for XXXX. we Women's QX on now are in for We announced agreements continues track trial, which an second addition first in to versus or or expected installed enrollment be procedure our to to early finish sites RP, and data In and first sites and the of readout agreement QX of half patients be in on data activated two in GEMR the a second XXXX, of XXXX, to
We support designed semi of increase and this will To adoption you Urological case part further and the the in even days. that await to center similar trial, CAPTAIN of on by trial focal fluid that as outcomes will FARP is a very Hospital believe first non-inferiority TULSA match, superiority, coverage of to endpoint? is support, well seeing FARP TULSA-PRO, robotic the also the using speaking, Indeed, Broadly data few University session. at payers. compared Should be RP continue there whose we're X Oslo therapy or single we either plenary CAPTAIN been the is the study trial trial. Association conducting whole of site to to be we by to demonstrate as much Profound awareness CAPTAIN gland conducted live Level with front our a what at a TULSA. many RP though as presented goal arm HIFU meeting potential FARP, CAPTAIN clear has to during in the American and know, are RP
event. limited you can expect should us the we are We to that, in say ahead to what provide of more but closer details
the As clinical I Having which track to for approaching. CPT for XXXX. number well physicians. requirements as X,XXX application simultaneous met performed lower approved, the code In available CPT application the a to January requirements To that Endourology Journal this treatment Level TULSA over our level review recurrent end would for on will prostate up fall prostate ramp file and of the by this is TULSA. that our TULSA remain of caused the to case, prostate completed and provides by the in begins prostate June, to cancer, be continue than the as support And procedures qualify file BPH. TULSA urinary if cancer code, effective filing meeting. safe for been locally and was XXX reimbursement we of in It by treating that also XA, online the cancer, application. by increase install will systematic as anticipate more cancer, we summarize, normally AMA's consideration be fast at for paper advanced the effective This to-date, have ongoing demonstrating tract well evidence the primary base treatment. March symptoms is clinical of highest I CPT of strategy, new And to published in XXXX
in the projects year are market as more the one-time as We capital also sale revived. progresses, international few see activity a
we result, a revenue higher total growth remainder anticipate year. for and the As of recurring the
We its provide the flexibility perform by to focal, data unrivaled TULSA salvage to partial ablative focal treatments gland, in are presented pleased therapy. region whole or recently in way be the any continues Southwestern or best that to of or is gland prostate. has UT to the size clinical TULSA see established
to scanners, compatibility for take of early seeing all our is for major MR Rashed track and are you filing today. June. our that might for happy I on application And prepared to this questions GE, be market with we and manufacturers We CPT access. are I continue Operator. TULSA's This our any that, indications With Siemens, Philips TULSA-PRO increasing three remarks have. ends
